Age-Related Macular Degeneration (AMD) Global Market Report 2022: Featuring F. Hoffman - La Roche, Bayer, Abbvie, GSK, Novartis, Regeneron Pharmaceuticals, Bausch Health & Alimera Sciences
24 janv. 2023 04h48 HE
|
Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis"...
Leber Congenital Amaurosis Market Is Estimated to Grow at CAGR Of 4.8%, 2022-2029 | Latest Industry Coverage by Douglas Insights
20 janv. 2023 01h23 HE
|
Douglas Insights
Douglas, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The Leber Congenital Amaurosis Market Report by Douglas Insights aims to inform about the details of growing developments, market share, and any localized...
Diabetic Macular Edema Treatment Global Market Report 2022: Intravitreal Implants Set to Take Center Stage
10 janv. 2023 07h13 HE
|
Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Diabetic Macular Edema Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
Global Diabetic Retinopathy Market Report 2022: Analysis on Key Drivers, Players, & Trends Fueling the Sector
27 oct. 2022 08h43 HE
|
Research and Markets
Dublin, Oct. 27, 2022 (GLOBE NEWSWIRE) -- The "Global Diabetic Retinopathy Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022
24 oct. 2022 13h05 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies, Inc. OTCQB: RTGN to Present at the Emerging Growth Conference. RetinalGeniX Technologies, Inc. (RTGN) is pleased to...
$12+ Billion Diabetic Retinopathy Market Size to Grow at a CAGR of 6.5% by 2028 | The Insight Partners
19 oct. 2022 10h09 HE
|
The Insight Partners
New York, Oct. 19, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Diabetic Retinopathy Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...
Macular Degeneration Treatment Global Market Report 2022: Continued Development of Advanced Therapies Presents Opportunities
08 sept. 2022 07h58 HE
|
Research and Markets
Dublin, Sept. 08, 2022 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Market Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global macular...
Vinay Mehindru, MD, MBA Appointed to RetinalGenix Technologies Inc. Board of Directors
26 juil. 2022 06h15 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- RetinalGenix™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today the appointment of Vinay Mehindru, MD, MBA to the...
RetinalGeniX Technologies, Inc. Acquires DNA/GPS Inc.
06 juil. 2022 08h00 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the acquisition of DNA/GPS Inc.,...
Worldwide Macular Degeneration Treatment Industry to 2027 - Featuring Iveric Bio, Novartis and Panoptica Among Others
09 juin 2022 08h03 HE
|
Research and Markets
Dublin, June 09, 2022 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...